Efficacy and Safety of Long-term Oral Staphylococcus Albicans Tablets in Patients With Bronchiectasis

NARecruitingINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

June 6, 2022

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Bronchiectasis
Interventions
DRUG

Staphylococcus and Neisseria Tablets

0.3 mg/ tablet, 4 tablets each time, 3 times a day (Shandong Qilu Pharmaceutical Co., LTD.), the course of treatment was more than 3 months.

OTHER

On-demand treatment

At the time of enrollment, patients with acute exacerbation of bronchiectasis were given routine treatment. For patients with stable bronchiectasis at the time of enrollment, they are treated as needed (that is, according to the needs of the disease, receive corresponding treatment).

Trial Locations (1)

250014

RECRUITING

Department of Respiratory, The First Affiliated Hospital of Shandong First Medical University, Jinan

All Listed Sponsors
lead

Qianfoshan Hospital

OTHER